PCI Biotech Holding Beheer
Beheer criteriumcontroles 2/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Ronny Skuggedal
Algemeen directeur
NOK 2.4m
Totale compensatie
| Percentage CEO-salaris | 82.8% |
| Dienstverband CEO | 11.1yrs |
| Eigendom CEO | 0.1% |
| Management gemiddelde ambtstermijn | geen gegevens |
| Gemiddelde ambtstermijn bestuur | 8.5yrs |
Recente managementupdates
Recent updates
Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -NOK 16m |
| Mar 31 2024 | n/a | n/a | -NOK 18m |
| Dec 31 2023 | NOK 2m | NOK 2m | -NOK 20m |
| Sep 30 2023 | n/a | n/a | -NOK 23m |
| Jun 30 2023 | n/a | n/a | -NOK 29m |
| Mar 31 2023 | n/a | n/a | -NOK 38m |
| Dec 31 2022 | NOK 2m | NOK 2m | -NOK 55m |
| Sep 30 2022 | n/a | n/a | -NOK 73m |
| Jun 30 2022 | n/a | n/a | -NOK 84m |
| Mar 31 2022 | n/a | n/a | -NOK 88m |
| Dec 31 2021 | NOK 2m | NOK 2m | -NOK 88m |
| Sep 30 2021 | n/a | n/a | -NOK 90m |
| Jun 30 2021 | n/a | n/a | -NOK 90m |
| Mar 31 2021 | n/a | n/a | -NOK 100m |
| Dec 31 2020 | NOK 3m | NOK 1m | -NOK 72m |
| Sep 30 2020 | n/a | n/a | -NOK 71m |
| Jun 30 2020 | n/a | n/a | -NOK 64m |
| Mar 31 2020 | n/a | n/a | -NOK 61m |
| Dec 31 2019 | NOK 2m | NOK 1m | -NOK 89m |
| Sep 30 2019 | n/a | n/a | -NOK 68m |
| Jun 30 2019 | n/a | n/a | -NOK 62m |
| Mar 31 2019 | n/a | n/a | -NOK 43m |
| Dec 31 2018 | NOK 2m | NOK 1m | -NOK 35m |
| Sep 30 2018 | n/a | n/a | -NOK 46m |
| Jun 30 2018 | n/a | n/a | -NOK 48m |
| Mar 31 2018 | n/a | n/a | -NOK 48m |
| Dec 31 2017 | NOK 1m | NOK 1m | -NOK 43m |
Compensatie versus markt: De totale vergoeding ($USD 220.76K ) Ronny } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de German markt ($USD 476.59K ).
Compensatie versus inkomsten: De vergoeding van Ronny is gestegen terwijl het bedrijf verliesgevend is.
CEO
Ronny Skuggedal (48 yo)
11.1yrs
Tenure
NOK 2,443,000
Compensatie
Mr. Ronny Skuggedal has been the Chief Financial Officer at PCI Biotech Holding ASA and PCI Biotech AS since joining in October 2013. He serves as Chief Executive Officer at PCI Biotech Holding ASA since S...
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Independent Chairman | 9.5yrs | NOK 395.00k | 0.33% € 17.4k | |
| Independent Director | 8.5yrs | NOK 260.00k | 0.035% € 1.8k | |
| Independent Director | 5.5yrs | NOK 260.00k | geen gegevens |
8.5yrs
Gemiddelde duur
69yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van 4QG wordt beschouwd als ervaren (gemiddelde ambtstermijn 8.5 jaar).